Corrilynn O Hileman
Biographic Data
| ID | 7804117 |
|---|---|
| NAME | Corrilynn O Hileman |
| GIVEN NAMES | Corrilynn |
| FAMILY NAME | O Hileman |
| SIGNATURE | HILEMAN C O |
| AFFILIATIONS | MetroHealth |
| ORCID | 0000-0001-9849-0914 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2020 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Trends in Buprenorphine Prescribing Among Adults with Opioid Use Disorder and Coexisting HIV or Viral Hepatitis, 2015–2025
We examined buprenorphine prescribing among adults in the United States with opioid use disorder or other opioid-related diagnoses and coexisting HIV, hepatitis B, or hepatitis C from 2015 to 2025. Using the TriNetX USA Minimal Date Shift Network, we constructed annual cohorts and assessed encounter-day buprenorphine prescribing, with and without chronic pain diagnoses. Prescribing rose from 6% in 2015 to 17% in 2020, then plateaued at 16–19% thr…
The impact of Covid-19 on cardiovascular health behaviors in people living with HIV
The COVID-19 pandemic’s impact on cardiovascular health behaviors including diet, physical activity, medication adherence, and self-care among people living with HIV (PLWH) remains unknown. Using qualitative analyses, we examined the impact of the COVID-19 pandemic on cardiovascular health behaviors among PLWH. Twenty-four PLWH were enrolled in this multisite study from September to October 2020. Individuals participated in semi-structured teleph…
The influence of healthcare financing on cardiovascular disease prevention in people living with HIV
Clinical Trial Registration Number: NCT03643705
No prominent works on this page.
The influence of healthcare financing on cardiovascular disease prevention in people living with HIV
Clinical Trial Registration Number: NCT03643705
The impact of Covid-19 on cardiovascular health behaviors in people living with HIV
The COVID-19 pandemic’s impact on cardiovascular health behaviors including diet, physical activity, medication adherence, and self-care among people living with HIV (PLWH) remains unknown. Using qualitative analyses, we examined the impact of the COVID-19 pandemic on cardiovascular health behaviors among PLWH. Twenty-four PLWH were enrolled in this multisite study from September to October 2020. Individuals participated in semi-structured teleph…
Trends in Buprenorphine Prescribing Among Adults with Opioid Use Disorder and Coexisting HIV or Viral Hepatitis, 2015–2025
We examined buprenorphine prescribing among adults in the United States with opioid use disorder or other opioid-related diagnoses and coexisting HIV, hepatitis B, or hepatitis C from 2015 to 2025. Using the TriNetX USA Minimal Date Shift Network, we constructed annual cohorts and assessed encounter-day buprenorphine prescribing, with and without chronic pain diagnoses. Prescribing rose from 6% in 2015 to 17% in 2020, then plateaued at 16–19% thr…
Disease (2 works) · Family medicine (2 works) · Gerontology (2 works) · HIV-related health complications and treatments (2 works) · Medicine (2 works) · Public health (2 works) · Buprenorphine (1 work) · Cardiac Health and Mental Health (1 work) · Gestational Diabetes Research and Management (1 work) · Health care (1 work)